Medicinal chemistry – Page 60
-
PodcastPotassium bromide
Did chemistry help control tension in the trenches? Brian Clegg investigates potassium bromide
-
Business
Novartis sells off blood diagnostics division
$1.7bn deal reinforces firm’s focus on core pharmaceuticals
-
News
Rough patch for India’s clinical trial industry
Bad publicity has added to the woes of an industry worried by regulatory uncertainty
-
-
OpinionNatural born chemists
Redesigning nature’s catalysts is tantalising but tricky, says Derek Lowe
-
News
Supreme court ruling brings clinical trials to a halt in India
Pressure from campaign group precipitates action that puts 162 drug trials on ice
-
BusinessGSK to apply for malaria vaccine approval
Infection protection drops over time, but the firm will go ahead with regulatory submission
-
Business
Japan confirms Novartis clinical trial data fabrication
Investigation into blood pressure blockbuster continues
-
FeatureSeek and destroy
Nanoparticles that can find specific targets before delivering a drug could change medicine. Akshat Rathi investigates
-
FeatureGiving screening the green light
Chemists are working with toxicologists at an earlier stage to avoid problems further down the chain, as Emma Davies reports
-
FeatureRe-arming the antibiotic arsenal
How can we make new antibiotics? Phillip Broadwith takes a look
-
CareersNon-profit pharma
Not-for-profit drug discovery is growing into a promising niche employment opportunity within the pharmaceutical industry. James Mitchell Crow investigates
-
BusinessService with a smile
Company profile: Charnwood Molecular is more than a run-of-the-mill contract synthesis provider
-
Business
GSK criticised for trial data secrecy
Italian research institute abandons collaboration over data access
-
NewsCall to overhaul liver toxicity testing
Outdated tests could be causing drug candidates to be scrapped without reason, say scientists
-
-
News
AllTrials releases plan for clinical trial reporting
Public campaign sets out how trial data should be made public
-
NewsAnimal testing failures put drug trial volunteers in danger
Poor pre-clinical data and an absence of negative results are pushing candidate molecules into the clinic too soon
-
FeatureAnimal pharm
Making drugs to treat animals is potentially lucrative – but also difficult, as Clare Sansom discovers
-
News
Former student sues Harvard for $10 million
PhD chemist seeks damages in row over patent royalties